CaaMTech
PrivateLast Round
Series A
Sep 8, 2021
Total Funding Raised
$22M
Momentum Score
25 /100
Company Overview
CaaMTech is a pharmaceutical drug discovery company that engineers and optimizes novel psychedelic-inspired small-molecule therapeutics to treat mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CaaMTech Comps
Public and private peers based on sector, stage, and business model.
CaaMTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 8, 2021 |
Key People
Founding team and executive leadership
CaaMTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noetic Fund | Series A |
| Mont Alto Capital | Series A |
| Kortschak Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 159% MoM, reaching 4.1K.
CaaMTech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CaaMTech's valuation, stock price, and market status.
